C J Soussy

1.7k total citations · 1 hit paper
14 papers, 1.2k citations indexed

About

C J Soussy is a scholar working on Pharmacology, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, C J Soussy has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Molecular Medicine and 5 papers in Applied Microbiology and Biotechnology. Recurrent topics in C J Soussy's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Antibiotic Use and Resistance (5 papers). C J Soussy is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Antibiotic Use and Resistance (5 papers). C J Soussy collaborates with scholars based in France, Germany and United Kingdom. C J Soussy's co-authors include Gunnar Kahlmeter, Arne C. Rodloff, Johan W. Mouton, Alasdair MacGowan, Martin Steinbakk, Christian G. Giske, Rafael Cantón, D F Brown, Roland Leclercq and Patrice Nordmann and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

C J Soussy

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EUCAST expert rules in antimicrobial susceptibility testing

2011 502 citations Roland Leclercq, Rafael Cantón et al. Clinical Microbiology and Infection profile →

Peers

C J Soussy

MM

PHARM

EPIDE

CB

ID

Mark E. Jones United States

D. Sofianou Greece

Elisabeth Löwdin Sweden

V. Krčméry Slovakia

T.G. Winstanley United Kingdom

M. Roussel‐Delvallez France

Marie-Dominique Kitzis France

Ronald N. Jones United States

R Cluzel France

Ronald N. Jones United States

Mark E. Jones United States

C J Soussy

743 ×1.3

MM

210 ×0.6

PHARM

402 ×1.2

EPIDE

226 ×1.0

CB

170 ×0.8

ID

Citations per year, relative to C J Soussy C J Soussy (= 1×) peers Mark E. Jones

Countries citing papers authored by C J Soussy

Since Specialization

Citations

This map shows the geographic impact of C J Soussy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Soussy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Soussy more than expected).

Fields of papers citing papers by C J Soussy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C J Soussy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Soussy. The network helps show where C J Soussy may publish in the future.

Co-authorship network of co-authors of C J Soussy

This figure shows the co-authorship network connecting the top 25 collaborators of C J Soussy. A scholar is included among the top collaborators of C J Soussy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C J Soussy. C J Soussy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Mouton, Johan W., D F Brown, Petra Apfalter, et al.. (2011). The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clinical Microbiology and Infection. 18(3). E37–E45. 213 indexed citations

2.

Leclercq, Roland, Rafael Cantón, Derek F. J. Brown, et al.. (2011). EUCAST expert rules in antimicrobial susceptibility testing. Clinical Microbiology and Infection. 19(2). 141–160. 502 indexed citations breakdown →

3.

Kahlmeter, Gunnar, D F Brown, F. W. Goldstein, et al.. (2006). European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clinical Microbiology and Infection. 12(6). 501–503. 237 indexed citations

4.

Sirot, J., Marie-Hélène Nicolas-Chanoine, H. Chardón, et al.. (2002). Susceptibility of Enterobacteriaceae to β-lactam agents and fluoroquinolones: a 3-year survey in France. Clinical Microbiology and Infection. 8(4). 207–213. 25 indexed citations

5.

Duval, J, C J Soussy, J. F. Acar, et al.. (1993). In-vitro antibacterial activity of cefepime: a multicentre study. Journal of Antimicrobial Chemotherapy. 32(suppl B). 55–61. 24 indexed citations

6.

Sirot, D., F. W. Goldstein, C J Soussy, et al.. (1992). Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrobial Agents and Chemotherapy. 36(8). 1677–1681. 122 indexed citations

7.

Kazmierczak, A, Eliane Siébor, J. F. Acar, et al.. (1991). [In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].. PubMed. 39(5). 384–90. 1 indexed citations

8.

Leclercq, Roland, et al.. (1988). [Resistance of nongroupable streptococci to beta-lactams. Detection by antibiogram and the activity of combinations of penicillin G and gentamicin].. PubMed. 36(5 Pt 2). 626–31. 2 indexed citations

9.

Legrand, Pierre, et al.. (1988). [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].. PubMed. 36(5). 425–9. 4 indexed citations

10.

Deforges, Lionel, C J Soussy, J Duval, et al.. (1983). [Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli].. PubMed. 31(5). 375–8. 1 indexed citations

11.

Fosse, T., C J Soussy, & J Duval. (1983). [In vitro study of combinations between third-generation cephalosporins and aminoglycosides on Enterobacteriaceae].. PubMed. 31(6). 483–7. 1 indexed citations

12.

Soussy, C J, et al.. (1981). [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].. PubMed. 132(3). 267–81. 10 indexed citations

13.

Mignon, François, et al.. (1976). Acute gastroduodenal lesions related to severe sepsis.. PubMed. 142(3). 377–80. 30 indexed citations

14.

Rapin, M, et al.. (1975). [Septicemias of superinfection in resucitation. Their prevention by restriction of antibiotics].. PubMed. 4(7). 483–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact